This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug ACLASTA contains one active pharmaceutical ingredient (API):

1 Zoledronic acid

Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption.

Read about Zoledronic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M05BA08 Zoledronic acid M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 9288W, 9350D
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526526701159419
Country: CA Health Products and Food Branch Identifier(s): 02269198
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00693807, 04392020, 04944241, 05006970, 05453930, 09166943, 09643596, 10068306, 10227874, 10857693, 11030004, 11100503, 11157377, 11874363, 12340787, 12457880, 14357102, 14367425, 15382148, 15434170
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 4469-MEE-1118
Country: EE Ravimiamet Identifier(s): 1201712, 1265666
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 418386
Country: FR Base de données publique des médicaments Identifier(s): 67306342
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 104230, 392262
Country: HK Department of Health Drug Office Identifier(s): 54084, 66154
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6016
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1005667, 1026398
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 051M2006
Country: NL Z-Index G-Standaard, PRK Identifier(s): 79790
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11849
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100137948
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64472001, W64472002
Country: SG Health Sciences Authority Identifier(s): 13192P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 10283281
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699504690019
Country: ZA Health Products Regulatory Authority Identifier(s): A39/34/0575

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.